Isolation of virus from a SARS patient and genome-wide analysis of genetic mutations related to pathogenesis and epidemiology from 47 SARS-CoV isolates.
Severe acute respiratory syndrome (SARS) caused by SARS-associated coronavirus (SARS-CoV) is a fatal disease. Prevention of future outbreaks is essential and requires understanding pathogenesis and evolution of the virus. We have isolated a SARS-CoV in China and analyzed 47 SARS-CoV genomes with the aims to reveal the evolution trends of the virus and provide insights into understanding pathogenesis and SARS epidemic. Specimen from a SARS patient was inoculated into cell culture. The presence of SARS-CoV was determined by RT-PCR and confirmed by electron microscopy. Virus was isolated followed by the determination of its genome sequences, which were then analyzed by comparing with other 46 SARS-CoV genomes. Genetic mutations with potential implications to pathogenesis and the epidemic were characterized. This viral genome consists of 29,728 nucleotides with overall organization in agreement with that of published isolates. A total of 348 positions were mutated on 47 viral genomes. Among them 22 had mutations in more than three genomes. Hot spots of nucleotide variations and unique trends of mutations were identified on the viral genomes. Mutation rates were different from gene to gene and were correlated well with periodical or geographic characteristics of the epidemic.
Zhu
Ying
Y
Key Laboratory of Virology, Ministry of Education College of Life Sciences, Wuhan University, Wuhan 430072, China.
Liu
Mo
M
Zhao
Weiguang
W
Zhang
Jianlin
J
Zhang
Xue
X
Wang
Ke
K
Gu
Chunfang
C
Wu
Kailang
K
Li
Yan
Y
Zheng
Congyi
C
Xiao
Gengfu
G
Yan
Huimin
H
Zhang
Jiamin
J
Guo
Deyin
D
Tien
Po
P
Wu
Jianguo
J
D000293:Adolescent; D002681:China / Q000453:epidemiology; D018076:DNA, Complementary / Q000737:chemistry / Q000302:isolation & purification; D019143:Evolution, Molecular; D016679:Genome, Viral; D006801:Humans; D008297:Male; D008854:Microscopy, Electron; D017720:Molecular Epidemiology; D008969:Molecular Sequence Data; D009154:Mutation; D020125:Mutation, Missense; D017354:Point Mutation; D012367:RNA, Viral / Q000032:analysis / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D045473:Severe acute respiratory syndrome-related coronavirus / Q000235:genetics* / Q000302:isolation & purification* / Q000472:pathogenicity; D017421:Sequence Analysis; D045169:Severe Acute Respiratory Syndrome / Q000453:epidemiology / Q000821:virology*; D014774:Virulence / Q000235:genetics
D018076:DNA, Complementary; D012367:RNA, Viral
Lancet. 2003 May 24;361(9371):1779-85
12781537
N Engl J Med. 2003 May 15;348(20):1953-66
12690092
J Virol. 2004 Jan;78(1):76-82
14671089
Science. 2004 Mar 12;303(5664):1666-9
14752165
N Engl J Med. 2003 May 15;348(20):1967-76
12690091
Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):6974-80
10860959
Lancet. 2003 Oct 25;362(9393):1353-8
14585636
Science. 2003 May 30;300(5624):1351
12775803
Zhonghua Liu Xing Bing Xue Za Zhi. 2003 May;24(5):350-2
12820925
Science. 2003 Nov 28;302(5650):1504-5
14645828
Lancet. 2003 Aug 16;362(9383):570-2
12932393
J Mol Biol. 2003 Aug 29;331(5):991-1004
12927536
Science. 2003 Oct 10;302(5643):276-8
12958366
N Engl J Med. 2003 Jul 10;349(2):187-8
12853594
Lancet. 2003 Nov 29;362(9398):1807-8
14654320
Science. 2003 May 30;300(5624):1394-9
12730500
Lancet. 2003 Dec 6;362(9399):1895-6
14667748
J Clin Virol. 2003 Dec;28(3):233-8
14522060
J Antimicrob Chemother. 1999 Nov;44 Suppl B:3-9
10877456